(Q43758147)

26 November 2017

title

Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases (English)

1 reference

26 November 2017

Rika Iwakiri

1

1 reference

26 November 2017

Masatsugu Ohta

2

1 reference

26 November 2017

Michiaki Mikoshiba

3

1 reference

26 November 2017

Hisashi Tsutsumi

4

1 reference

26 November 2017

Toshiro Kumakawa

5

1 reference

26 November 2017

Mayumi Mori

6

1 reference

26 November 2017

language of work or name

1 reference

1 January 2002

1 reference

International Journal of Hematology

26 November 2017

published in

1 reference

26 November 2017

volume

75

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

45-50

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02981978

26 November 2017

exact match

0 references

cites work

Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapy

1 reference

12 December 2020

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia

1 reference

12 December 2020

Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia

1 reference

12 December 2020

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myélobla

1 reference

12 December 2020

Survival in acute leukemia in elderly patients. No improvement in the 1980s

1 reference

12 December 2020

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group

1 reference

12 December 2020

Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study

1 reference

12 December 2020

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients.

1 reference

12 December 2020

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

12 December 2020

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organiz

1 reference

12 December 2020

Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia

1 reference

12 December 2020

Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival

1 reference

12 December 2020

Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors

1 reference

12 December 2020

Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly

1 reference

12 December 2020

Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission

1 reference

12 December 2020

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisat

1 reference

12 December 2020

Acute myeloblastic leukaemia in the elderly: biology, prognostic factors and treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02981978

1 reference

release_pdtt5hldnbbb7mt4nwqgupklpy

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pdtt5hldnbbb7mt4nwqgupklpy

24 November 2022

mapped directly with Wikidata item

1 reference